申请人:Kowa Co., Ltd.
公开号:US20030060461A1
公开(公告)日:2003-03-27
A cyclic diamine compound of formula (1):
1
wherein R
1
and R
2
are individually a hydrogen atom or a methoxy group, provided R
1
is a methoxy group when R
2
is a hydrogen atom, or a hydrogen atom when R
2
is a methoxy group; A is an oxygen atom, a sulfur atom, CH═CH, CH═N or NR
3
, in which R
3
is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR
4
, in which R
4
is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5,
an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.
化合物的分子式为(1):1,其中R1和R2分别为氢原子或甲氧基,当R2为氢原子时,R1为甲氧基,当R2为甲氧基时,R1为氢原子。A为氧原子、硫原子、CH═CH、CH═N或NR3,其中R3为氢原子或较低的烷基、羟基较低的烷基、较低的烷氧基较低的烷基、芳基或芳基较低的烷基;B为氮原子、CH或CR4,其中R4为氢原子或较低的烷基、羟基较低的烷基、较低的烷氧基较低的烷基、芳基或芳基较低的烷基;m为1或2;n为1至5的数字,其酸加成盐或水合物。该化合物具有细胞黏附抑制作用,可用于治疗过敏、哮喘、风湿病、动脉硬化和炎症。